Mark Ng

Mark Ng has a solid work experience in the field of scientific research and development. Mark has worked as a Senior Scientist at two different companies, Affini-T Therapeutics and Novartis Institutes for BioMedical Research (NIBR). At Affini-T Therapeutics, Mark is currently serving as a Senior Scientist in TCR Discovery, starting from January 2023. Prior to that, at NIBR, they held the positions of Senior Scientist II and Senior Scientist I, starting from November 2020 and working until December 2022.

Before joining NIBR, Mark gained experience at Repertoire Immune Medicines, where they worked as an Associate Scientist from October 2020 to November 2020 and as a Senior Research Associate in Protein Engineering from June 2018 to October 2020.

Furthermore, Mark has also worked at Northern Biologics as an Associate Research Scientist from August 2016 to March 2018, and earlier, as an Intern for a three-month period from May 2016 to August 2016. Prior to that, Mark started their professional journey as a Summer Research Student at the University of Toronto for a five-month period from April 2013 to September 2013.

Mark Ng completed their Honours Bachelor of Science degree in Health and Disease, Cell and Molecular Biology at the University of Toronto between 2009 and 2013. Following this, they pursued a Master of Science degree in Molecular Genetics at the same institution from 2013 to 2016.